Using CD3+/CD28+ T cells isolated from immune competent mice, we observed that NextA did not induce major changes in the production of either IFNγ and IL2 (Fig. 5B), implying that the anti-tumor activity of HDAC6i was not mediated by the direct action of this drug on T cells. This evidence concerns the gene IL2 and neoplasm.